InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Mossler Mark. Officer active across 1 company, notably C4 Therapeutics, Inc.. Aggregated, 2 filings have been published. Activity tracked since 14 February 2024. The latest transaction was disclosed on 14 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations